Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer.
Clin Cancer Res. 2023 Aug 1;29(15):2767-2773. doi: 10.1158/1078-0432.CCR-23-0112.
Clin Cancer Res. 2023.
PMID: 37260292
Free PMC article.
Preclinical data suggest that cycling treatment with 17beta-estradiol followed by estrogen deprivation can control tumor growth long-term. PATIENTS AND METHODS: Postmenopausal women with advanced ER+/HER2- breast cancer with recurrence or progression on 1 antiestrogen or a …
Preclinical data suggest that cycling treatment with 17beta-estradiol followed by estrogen deprivation can control tumor growth long-term …
Visual Representations of Risk Enhance Long-Term Retention of Risk Information: A Randomized Trial.
Arrick BA, Bloch KJ, Colello LS, Woloshin S, Schwartz LM.
Arrick BA, et al.
Med Decis Making. 2019 Feb;39(2):100-107. doi: 10.1177/0272989X18819493. Epub 2019 Jan 11.
Med Decis Making. 2019.
PMID: 30632890
Clinical Trial.
Item in Clipboard
Cite
Cite